This gene encodes a C2H2 type zinc-finger protein by its similarity to the mouse Bcl11a/Evi9 protein. The corresponding mouse gene is a common site of retroviral integration in myeloid leukemia, and may function as a leukemia disease gene, in part, through its interaction with BCL6. During hematopoietic cell differentiation, this gene is down-regulated. It is possibly involved in lymphoma pathogenesis since translocations associated with B-cell malignancies also deregulates its expression. Five alternatively spliced transcript variants of this gene, which encode distinct isoforms, have been reported.
Saiki Y, Yamazaki Y, Yoshida M, et al. (2001). "Human EVI9, a homologue of the mouse myeloid leukemia gene, is expressed in the hematopoietic progenitors and down-regulated during myeloid differentiation of HL60 cells.". Genomics70 (3): 387–91. doi:10.1006/geno.2000.6385. PMID11161790.
Nagase T, Nakayama M, Nakajima D, et al. (2001). "Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.". DNA Res.8 (2): 85–95. doi:10.1093/dnares/8.2.85. PMID11347906.
Martín-Subero JI, Gesk S, Harder L, et al. (2002). "Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.". Blood99 (4): 1474–7. doi:10.1182/blood.V99.4.1474. PMID11830502.
Küppers R, Sonoki T, Satterwhite E, et al. (2002). "Lack of somatic hypermutation of IG V(H) genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene.". Leukemia16 (5): 937–9. doi:10.1038/sj.leu.2402480. PMID11986957.
Weniger MA, Pulford K, Gesk S, et al. (2006). "Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma.". Leukemia20 (10): 1880–2. doi:10.1038/sj.leu.2404324. PMID16871282.